Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Examine the Psychosocial Impacts of COVID-19 Pandemic.
NCT05052333 · View on ClinicalTrials.gov ↗
Study Summary
This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological distress (Kessler 10), post-traumatic stress (PTSD Checklist for DSM-5), post-traumatic growth (Posttraumatic Growth Inventory), and a novel pandemic-related stress (COVID Psychosocial Impacts Scale). Data was collected employing either a unilingual (in native language) or bilingual online survey (with English as a second language) from participants (N=2574) aged 18 and above using a non-probability convenient sampling. The findings enabled us to examine the psychosocial impacts of COVID-19, validate the translations of the CPIS and standardized measures; and determine the trajectory of study variables with pandemic exposure.
Conditions Studied
Study Locations (9)
Other
- Universitas Ahmad Dahlan — Yogyakarta
- Universitas Gadjah Mada — Yogyakarta
- University of Social Welfare and Rehabilitation Sciences — Tehran
- Ibn Sina University of Medical and Pharmaceutical Sciences — Baghdad
- Mustansiriyah University — Baghdad
- Universiti Malaya — Kuala Lumpur
- International Islamic University — Islamabad
- Hasan Kalyoncu Üniversitesi — Gaziantep
Washington
- University of Washington — Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,574 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-10-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05052333
The ClinicalTrials.gov registry entry for NCT05052333 describes a study currently listed as completed. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 2,574 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Otago, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with COVID-19 Pandemic appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05052333 reports 9 study locations spanning 2 distinct geographic areas — top geographies include Other, Washington. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05052333 about?
NCT05052333 is a clinical study titled "Examine the Psychosocial Impacts of COVID-19 Pandemic.". This is an observational study examining the psychosocial impacts of the COVID-19 pandemic in seven low-and-middle income countries (Indonesia, Iran, Iraq, Malaysia, Pakistan, Somaliland, and Turkiye). The data was obtained on standardised measures of wellbeing (WHO Well-Being Index), psychological ...
What is the current status of trial NCT05052333?
This trial is currently completed. The enrollment target is 2,574 participants. The study started on 2021-12-01. Estimated completion is 2023-10-31.
What conditions does trial NCT05052333 study?
This clinical trial studies the following conditions: COVID-19 Pandemic, Psychosocial Impacts. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT05052333?
This trial is sponsored by University of Otago, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05052333 being conducted?
This trial has 9 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.